“Spot-on” evidence-based nursing care – New research and developments

Dear EAUN members,

The growing evidence in urology nursing care is amazing!

With this column, the EAUN SIG Groups want to put the spotlight on recent publications in their field of interest. This month’s articles have been carefully
chosen because of the scientific value from PubMed and represent different methods and approaches in research and development in urological nursing care. We hope this new initiative will have your attention and continuously provide information on “spot-on” urological nursing care.

If you would like to inform us and your colleagues about new initiatives or exiting developments in one of the special interest fields you can contact us using the email addresses below.

Best regards
The SIG Chairs

_____________________________________________________________________________________
Selected from PubMed November-December 2019

Bladder Cancer
• Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Bessa A, Maclennan S, Enting D, et al. Eur Urol. 2019 Aug;76(2):258-259. doi:10.1016/j.eururo.2019.01.031. Epub 2019 Jan 31. Pubmed PMID: 30712969.
https://www.ncbi.nlm.nih.gov/pubmed/30712969
• Intravesical device-assisted therapies for non-muscle invasive bladder cancer. Tan WS, Kelly JD. Nat Rev Urol. 2018 Nov;15(11):667-685. doi:10.1038/s41585- 018-0092-z. Review. Pubmed PMID: 30254383.
https://www.ncbi.nlm.nih.gov/pubmed/30254383
• Health-related quality of life after BCG or MMC induction for on-muscle invasive bladder cancer. Siracusano S, Silvestri T, Bassi S, et al. Can J Urol. 2018 Oct;25(5):9480-9485. Pubmed PMID: 30281005.
https://www.ncbi.nlm.nih.gov/pubmed/30281005
• Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study. Oughton JB, Poad H, Twiddy M, et al; BRAVO study group. BMJ Open. 2017 Aug 11;7(8):e017913. doi: 0.1136/bmjopen-2017-017913. PubMed PMID: 28801444; PubMed Central PMCID: PMC5724134.
https://www.ncbi.nlm.nih.gov/pubmed/28801444

Prostate Cancer
• Pain, fatigue and depression symptom cluster in survivors of prostate cancer. Baden M, Lu L, Drummond FJ, Gavin A, Sharp L. Support Care Cancer. 2020 Jan 24. doi: 10.1007/s00520-019-05268-0. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31980895
• Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and preexisting Cardiovascular Disease. Margel D, Peer A, Ber Y, Shavit-Grievink L, Tabachnik T, Sela S et al. J Urol. 2019 Dec;202(6):1199-1208. doi: 10.1097/
JU.0000000000000384. Epub 2019 Jun 12.
https://www.ncbi.nlm.nih.gov/pubmed/31188734
• “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now. Grummet J, Gorin MA, Popert R3, O’Brien T, Lamb AD, Hadaschik B, Radtke JP et al. Prostate Cancer Prostatic Dis. 2020 Jan 13. doi: 10.1038/s41391-020-0204-8. [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/?term=trexit+2020

Endourology
• Current European Trends in Endoscopic Imaging and Transurethral Resection of Bladder Tumors, Frank Waldbillig, Simon Hein, Britta Grüne, Rodrigo Suarez-Ibarrola, Evangelos Liatsikos, Georg Salomon, Alexander Reiterer, Christian Gratzke, Arkadiusz Miernik, Maximilian C Kriegmair, Manuel Ritter. J Endouro. 2019 Nov 19. DOI: 10.1089/end.2019.0651. PMID: 31617417.
https://www.ncbi.nlm.nih.gov/pubmed/31617417
• Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review  and Meta-Analysis of Studies Comparing Open With Robotic Counterparts. Lazaros Tzelves, Andreas Skolarikos, Panagiotis Mourmouris, Lazaros Lazarou, Nikolaos Kostakopoulos, Dimitrios K Manatakis, Ali Riza Kural. J Endourol, 33 (12), 971-984. Dec 2019. DOI:10.1089/end.2019.0226. PMID: 31161777
https://www.ncbi.nlm.nih.gov/pubmed/31161777
• Robot Assisted Surgery of the Vena Cava: Perioperative Outcomes, Technique, and Lessons Learned at The Mayo Clinic. Kyle M Rose, Anojan K Navaratnam, Haidar M Abdul-Muhsin, Kassem S Faraj, Sarah A Eversman, Adyr A Moss 2, William G Eversman 3, William M Stone 4, Samuel R Money 4, Victor J Davila 4, Erik P Castle 1. J Endourol , 33 (12), 1009-1016. Dec 2019. DOI: 10.1089/end.2019.0429. PMID: 31588787.
https://www.ncbi.nlm.nih.gov/pubmed/31588787
• Postoperative Complications After Robotic Partial Nephrectomy. Jessica Connor, Sai K Doppalapudi, Ethan Wajswol, Radhika Ragam, Benjamin Press, Thaiphi Luu, Helaine Koster, Tenzin-Lama Tamang, Mutahar Ahmed, Gregory Lovallo, Ravi Munver, Michael D Stifelman. J Endourol, 34 (1), 42-47. Jan 2020. DOI:  10.1089/end.2019.0434. PMID: 31588795.
https://www.liebertpub.com/doi/abs/10.1089/end.2019.0434
_____________________________________________________________________________________

Bente Thoft Jensen, Chair, EAUN Special Interest Group – Bladder Cancer
b.thoft@eaun.org

Lawrence Drudge-Coates, Chair, EAUN Special Interest Group – Prostate Cancer
l.drudge-coates@eaun.org

Anna Mohammed, Chair, EAUN Special Interest Group – Endourology
a.mohammed@eaun.org